"Cannabidiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compound isolated from Cannabis sativa extract.
| Descriptor ID |
D002185
|
| MeSH Number(s) |
D02.455.849.090.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cannabidiol".
Below are MeSH descriptors whose meaning is more specific than "Cannabidiol".
This graph shows the total number of publications written about "Cannabidiol" by people in this website by year, and whether "Cannabidiol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2017 | 6 | 2 | 8 |
| 2018 | 6 | 3 | 9 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cannabidiol" by people in Profiles.
-
COVID-19 and Cannabidiol (CBD). J Addict Med. 2021 Sep-Oct 01; 15(5):355-356.
-
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021 08 02; 4(8):e2120603.
-
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status. Biomed Pharmacother. 2021 Oct; 142:111956.
-
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):327-329.
-
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci. 2021 Feb 17; 22(4).
-
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study. Pharm Stat. 2021 05; 20(3):675-691.
-
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? Cannabis Cannabinoid Res. 2021; 6(1):7-18.
-
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19? Curr Pharm Des. 2021; 27(13):1564-1578.
-
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Int J Biol Macromol. 2021 Jan 31; 168:474-485.
-
In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging (Albany NY). 2020 11 22; 12(22):22425-22444.